Valganciclovir versus IV ganciclovir for therapy of cytomegalovirus viremia: has victory been achieved?
- PMID: 17697259
- DOI: 10.1111/j.1600-6143.2007.01925.x
Valganciclovir versus IV ganciclovir for therapy of cytomegalovirus viremia: has victory been achieved?
Comment on
-
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.Am J Transplant. 2007 Sep;7(9):2106-13. doi: 10.1111/j.1600-6143.2007.01910.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640310 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
